Report cover image

Event Management Software Market Share, Size, Trends, Industry Analysis Report, By Component (Software, Services); By Deployment Mode (Cloud, On-premises); By Organization Size; By End-Use; By Region; Segment Forecast, 2022 - 2030

Published Sep 01, 2025
Length 116 Pages
SKU # PLRS20470327

Description

The global event management software market size is expected to reach USD 42.57 Billion by 2034 according to a new study by Polaris Market Research. The report “Event Management Software Market Share, Size, Trends, Industry Analysis Report, By Component (Software, Services), By Deployment Mode, By Organization Size, By End Use, and By Region -Market Forecast, 2025 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The industry is expected to be driven by the increased number of platforms for marketing and the enhanced use of social media for sales promotion and planning. According to Pewresearch.org, social media adoption in 2005 was low, with only 5% of American adults using at least one of these systems. By 2011, that figure had increased to half of all Americans, and by 2021, 72% of the population would use some form of social media.

Also, as per the Our World in data, Facebook, the biggest social networking platform, has around 2.4 Bn users. Other sites, such as YouTube and Whatsapp, have over one billion users. These figures are staggering: the world population is 7.7 billion individuals, with at least 3.5 billion of use the internet. Further, each social media platform serves a distinct purpose, and it is critical to use them correctly. Facebook focuses on engagement and awareness, whereas Twitter focuses on conversations.

Twitter is the most popular platform for specialist networking and sharing industry updates, whereas YouTube is strongly video-focused and caters to a wide range of audiences. Social signals are one of the most important factors in online promotion for their immediate impact on the supreme brand loyalty, higher lead generation rates, and long-term engagement opportunities with the target audience. Thus, the rising number of social media users has increased the demand for marketing through social sites, boosting the demand for this management application.

Based on the organization size, the SMEs segment accounted for the leading share in the industry. The enhanced market competition and brand marketing have prompted SMEs to spend on this management application and services to reach more opportunities and participants and successfully host events for business growth.

Major players such as Rainfocus, Aventri, Bizzabo, Certain, Cvent, Eventbrite, Eventmobi, Hopin, Meeting Evolution, Regpack, Eventzilla, Ungerboeck, Xing Events, Active Network, and Zoho are some key players operating in the global market. In January 2022, Sunstone and Camden Partners invested in MeetingPlay and Aventri as part of their growth equity investment. The merged entity will be one of the largest technology companies in the world, serving customers and clients on a scale.

Polaris Market Research has segmented the event management software market report based on component, deployment mode, organization size, end use, and region:

Event Management Software, Component Outlook (Revenue - USD Billion, 2020 - 2034)

Software

Planning

Venue Management

Registration and Ticketing

Marketing

Analytics and Reporting Software

Onsite Technology

Content Management Software

Visitor Management Software

Others

Services

Managed Services

Professional Services

§ Consulting

§ Deployment and Integration

§ Support and Maintenance

Event Management Software, Deployment Mode Outlook (Revenue - USD Billion, 2020 - 2034)

Cloud

On-premises

Event Management Software, Organization Size Outlook (Revenue - USD Billion, 2020 - 2034)

Small & Medium-sized Enterprises

Large Enterprises

Event Management Software, End-Use Outlook (Revenue - USD Billion, 2020 - 2034)

Organizers and Planners

Corporate

Government

Education

Others

Event Management Software, Regional Outlook (Revenue - USD Billion, 2020 - 2034)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Spain

Netherlands

Russia

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

116 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. U.S. Cell and Gene Therapy Clinical Trials Market Insights
4.1. Cell and Gene Therapy Clinical Trials Market – Market Snapshot
4.2. Cell and Gene Therapy Clinical Trials Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising Rare Disease Research
4.2.1.2. Robust Funding Ecosystem
4.2.2. Restraints and Challenges
4.2.2.1. High Initial Investment
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Cell and Gene Therapy Clinical Trials Market Indication Trends
4.6. Value Chain Analysis
5. U.S. Cell and Gene Therapy Clinical Trials Market, by Phase
5.1. Key Findings
5.2. Introduction
5.2.1. U.S. Cell and Gene Therapy Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
5.3. Phase I
5.3.1. U.S. Cell and Gene Therapy Clinical Trials Market, by Phase I, 2020-2034 (USD Billion)
5.4. Phase II
5.4.1. U.S. Cell and Gene Therapy Clinical Trials Market, by Phase II, 2020-2034 (USD Billion)
5.5. Phase III
5.5.1. U.S. Cell and Gene Therapy Clinical Trials Market, by Phase III, 2020-2034 (USD Billion)
5.6. Phase IV
5.6.1. U.S. Cell and Gene Therapy Clinical Trials Market, by Phase IV, 2020-2034 (USD Billion)
6. U.S. Cell and Gene Therapy Clinical Trials Market, by Indication
6.1. Key Findings
6.2. Introduction
6.2.1. U.S. Cell and Gene Therapy Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
6.3. Oncology
6.3.1. U.S. Cell and Gene Therapy Clinical Trials Market, by Oncology, 2020-2034 (USD Billion)
6.4. Cardiology
6.4.1. U.S. Cell and Gene Therapy Clinical Trials Market, by Cardiology, , 2020-2034 (USD Billion)
6.5. CNS
6.5.1. U.S. Cell and Gene Therapy Clinical Trials Market, by CNS, 2020-2034 (USD Billion)
6.6. Musculoskeletal
6.6.1. U.S. Cell and Gene Therapy Clinical Trials Market, by Musculoskeletal, 2020-2034 (USD Billion)
6.7. Infectious diseases
6.7.1. U.S. Cell and Gene Therapy Clinical Trials Market, by Infectious diseases, 2020-2034 (USD Billion)
6.8. Dermatology
6.8.1. U.S. Cell and Gene Therapy Clinical Trials Market, by Dermatology, 2020-2034 (USD Billion)
6.9. Endocrine, metabolic, genetic
6.9.1. U.S. Cell and Gene Therapy Clinical Trials Market, by Endocrine, metabolic, genetic, 2020-2034 (USD Billion)
6.10. Immunology & inflammation
6.10.1. U.S. Cell and Gene Therapy Clinical Trials Market, by Immunology & inflammation, 2020-2034 (USD Billion)
6.11. Ophthalmology
6.11.1. U.S. Cell and Gene Therapy Clinical Trials Market, by Ophthalmology, 2020-2034 (USD Billion)
6.12. Hematology
6.12.1. U.S. Cell and Gene Therapy Clinical Trials Market, by Hematology, 2020-2034 (USD Billion)
6.13. Gastroenterology
6.13.1. U.S. Cell and Gene Therapy Clinical Trials Market, by Gastroenterology, 2020-2034 (USD Billion)
6.14. Others
6.14.1. U.S. Cell and Gene Therapy Clinical Trials Market, by Others, 2020-2034 (USD Billion)
7. Competitive Landscape
7.1. Expansion and Acquisition Analysis
7.1.1. Expansion
7.1.2. Acquisitions
7.2. Partnerships/Collaborations/Agreements/Exhibitions
8. Company Profiles
8.1. Charles River Laboratories
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Recent Development
8.2. ICON Plc
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Recent Development
8.3. IQVIA
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Recent Development
8.4. LabCorp
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Recent Development
8.5. Medpace
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Recent Development
8.6. Novotech
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Recent Development
8.7. PAREXEL International Corp.
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Recent Development
8.8. Syneos Health
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Recent Development
8.9. Thermo Fisher Scientific, Inc.
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Recent Development
8.10. Veristat, LLC
8.10.1. Company Overview
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Recent Development
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.